The Prediabetes Show - Episode 2: Catching It Before Progression-A Window of Opportunity? - Video

On this Prediabetes day presenting episode 2 of prediabetes show Catching It Before Progression: A Window of Opportunity?. Joining us in today’s discussion are Dr. Shachin Kumar Gupta, Consultant Diabetologist at Krishna Diabetes & Educational Research Centre, Bhopal, Madhya Pradesh & Dr. Mayur Agarwal, Founder and Director of Hormone India Diabetes and Endocrine Centre, Bhopal, Madhya Pradesh.

India is in the grip of a growing prediabetes epidemic—with more people affected by prediabetes than by type 2 diabetes itself. This isn't just a warning stage anymore. Mounting evidence shows that complications—vascular, renal, even retinal—can begin as early as the prediabetic phase.

They answer the following questions;

1) What does the term prediabetes truly signify from a pathophysiological standpoint?

2) Complications of prediabetes

3) An Indian study last year found 50% of prediabetic men have ED. What is the clinical view on this link?

4) Patients are generally comfortable reporting ED to their family physicians. Is there an opportunity to sensitise the need to screen this patient population for prediabetes, as both affect the young/middle-aged adults?

5) Which co-morbidities should sensitize a physician to think of prediabetes in a patient visiting his clinic?

6) Should we consider proactively identifying and treating certain categories of prediabetes patients with pharmacological intervention?

7) How to improve the opportunistic screening of prediabetes in the community, in patients who visit clinics and their peers?

8) When to use metformin in prediabetes – a DCGI-approved pharmacological agent for prediabetes in clinical practice?